Cargando…
Interaction of Onset and Duration of Diabetes on the Percent of GAD and IA-2 Antibody–Positive Subjects in the Type 1 Diabetes Genetics Consortium Database
OBJECTIVE: GAD antibodies (GADA) are more common in type 1 diabetic subjects diagnosed at an older age, whereas insulinoma-antigen 2 antibodies (IA-2A) are more common in subjects with younger onset. The prevalence of both antibodies decreases with longer duration of type 1 diabetes. We evaluated th...
Autores principales: | Tridgell, David M., Spiekerman, Charles, Wang, Richard S., Greenbaum, Carla J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064062/ https://www.ncbi.nlm.nih.gov/pubmed/21330643 http://dx.doi.org/10.2337/dc10-1903 |
Ejemplares similares
-
Targeting IA-2 and GAD65 as a Cost-Saving Approach for Antibody Testing in Children With New-Onset Diabetes
por: Kanner, Lauren, et al.
Publicado: (2019) -
Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
por: Pörksen, Sven, et al.
Publicado: (2010) -
Recognition of Posttranslationally Modified GAD65 Epitopes in Subjects With Type 1 Diabetes
por: McGinty, John W., et al.
Publicado: (2014) -
Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune Diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4
por: Lampasona, Vito, et al.
Publicado: (2010) -
PSUN257 Acute Onset Diabetes and GAD Antibody Positivity After COVID-19
por: Wilson, Jessica
Publicado: (2022)